Global Aortic Valve Replacement Devices Market Report and Forecast 2025-2034

Aortic Valve Replacement Devices Market Growth

To accelerate the adoption of aortic valve replacement devices in underdeveloped areas, stakeholders in the healthcare segment are focusing on improving the access of the population to interventional cardiology and cardiothoracic surgery specialities. In addition, a rise in educational campaigns to spread awareness regarding aortic valve diseases will increase the use of these devices in the treatment procedure.

Figure: World Population of the Elderly (In Million)

As the number of elderly patients with aortic valve stenosis and various other comorbidities is growing, the adoption of less invasive therapies is increasing, as surgeries pose a significant risk to their life. Additionally, the expanding geriatric population in Asian countries is also expected to enhance the adoption of minimally invasive aortic valve replacement procedures.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Key Trends and Developments

Aortic Valve Replacement Devices Market Trends

Aortic valve stenosis cases are increasing in numbers around the globe with a growing geriatric population and the prevalence of atherosclerosis. The geriatric population is highly susceptible to aortic valve conditions, particularly if they have cardiovascular risk factors such as high cholesterol and a history of smoking, which increase their chances for developing aortic valve calcification, requiring valve replacement. Patients aged 75 and above tend to have symptomatic and severe aortic stenosis and are investing in minimally invasive aortic valve replacement procedures to reduce their symptoms.

People aged 75 and above are inclined towards less invasive transcatheter aortic valve replacements as conducting an open-heart surgery on them is risky as they are weak and may be suffering from multiple other diseases.

Additionally, procedures such as the SU-AVR, minimally invasive aortic valve replacement (MIAVR), and transcatheter aortic valve implantation/transcatheter aortic valve replacement (TAVI/TAVR) are being used to overcome the shortcomings of surgical AVRs.

Heart defects such as aortic valves with missing valve openings, incorrect valve size or shape, or blood flowing backwards are increasing the need for aortic valve replacement devices. Some unhealthy habits include a sedentary lifestyle with little to no exercise, alcohol consumption beyond safety limits, excessive stress damaging heart valves, and having a diet high in salt.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Aortic Valve Replacement Devices Industry Segmentation

Aortic Valve Replacement Devices Market Share

Based on surgery type, minimally invasive surgery accounts for a significant share of the market

Minimally invasive aortic valve replacement surgeries are preferred by people and healthcare professionals as they prevent excess blood loss during the surgery, involve a lower risk of infection, and leave relatively fewer scars on the patient's body as they involve smaller chest incisions compared to open-heart surgery.

Minimally invasive heart surgeries are associated with benefits like a shorter hospital stay, and faster recovery, and are less painful than the traditional methods.

Open-heart aortic valve replacement surgeries are advisable for patients who need to undergo multiple coronary bypass processes or complex cardiovascular operations.

Based on product type, TAVR significantly contributes to the global aortic valve replacement devices market revenue

The enhanced safety and fast recovery times offered by TAVR (transcatheter aortic valve replacement) have boosted its utilisation as an effective treatment for severe aortic stenosis among geriatric patients. Innovations in the design of valve prosthesis and technological advancements in its haemodynamic performance, along with the availability of data based on trials to establish the efficacy of TAVR, are expected to widen the scope of TAVR in low-risk and immediate patient groups.

Leading Companies in the Aortic Valve Replacement Devices Market

Other notable players operating in the global aortic valve replacement devices market are Artivion, Inc, and Abbott Laboratories, among others.

Aortic Valve Replacement Devices Market Analysis by Region

North America is a key market for aortic valve replacement devices, with the US leading the way

North America remains a significant market, supported by the presence of advanced medical facilities, well-established healthcare infrastructure, and increasing geriatric population. In the United States, heart disease is the major cause of death for both men and women, and aortic stenosis, in particular, is one of the most common heart valve illnesses, affecting Americans over the age of 75 years. While surgical aortic valve replacement/implantation (SAVR, or SAVI) is the standard treatment for patients with severe aortic stenosis, transcatheter aortic valve replacement/implantation (TAVR, or TAVI) has established as a reliable and robust alternative for elderly patients who are at high risk for open surgery due to age, frailty, and other factors.

Meanwhile, the growing geriatric population and the rising incidences of aortic stenosis in the Asia Pacific have bolstered the use of TAVR in clinical practices owing to its minimally invasive procedure, fast recovery times, and low mortality rates.

The Japanese government has been providing grants for innovative sutureless aortic heart valve, and unlike various other Asian countries, the national government also funds TAVI, enhancing the domestic accessibility to versatile aortic valve replacement devices.

Read Our Top Selling Reports

India Disposable Medical Gloves Market

Latin America In-vitro Diagnostics Market

Global Implantable Medical Devices Market

Health Economics and Outcomes Research (HEOR) Market

Latin America Advanced Wound Care Market

Global Acute Kidney Injury Treatment Market

Global JE (Japanese Encephalitis) Vaccine Market

North America Laboratory Informatics Market

Global Laboratory Information System Market

South Africa Orthopaedic Braces and Supports Market

Aortic Valve Replacement Devices Market Report Snapshots

Aortic Valve Replacement Devices Market Size

Aortic Valve Replacement Devices Market Growth

Aortic Valve Replacement Devices Market Trends

Aortic Valve Replacement Devices Market Share

Aortic Valve Replacement Devices Companies

Aortic Valve Replacement Devices Market Regional Analysis